• 1
    Porte, R, Ploeg, R, Hansen, B, Bockel, Jv, Thorogood, J, Persijn, G, et al. Long-term graft survival after liver transplantation in the UW era: late effects of cold ischemia and primary dysfunction. European Multicentre Study Group. Transpl Int 1998; 11[suppl 1]: 164167.
  • 2
    Morris, P, Johnson, R, Fuggle, S, Belger, M, Briggs, J. Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. HLA Task Force of the Kidney Advisory Group of the United Kingdom Transplant Support Service Authority (UKTSSA). Lancet 1999; 354: 11471152.
  • 3
    Cho, Y, Terasaki, P, Cecka, J, Gjertson, D. Transplantation of kidneys from donors whose hearts have stopped beating. N Engl J Med 1998; 338: 221225.
  • 4
    Metcalfe, M, Butterworth, P, White, S, Saunders, R, Murphy, G, Taub, N, et al. A Case-control comparison of the results of renal transplantation from heart-beating and non-heart-beating donors. Transplantation 2001; 71: 15561559.
  • 5
    Rudich, S, Kaplan, B, Magee, J, Arenas, J, Punch, J, Kayler, L, et al. Renal transplantations performed using non-heart-beating organ donors: going back to the future. Transplantation 2002; 74: 17151720.
  • 6
    Sicular, A, Moore, F. The post mortem survival of tissues. The effect of time and temperature on the survival of liver as measured by glucose oxidation rate. J Surg Res 1961; 1: 16.
  • 7
    Mcanulty, J, Ametani, M, Southard, J, Belzer, F. Effect of hypothermia on intracellular Ca2+ in rabbit tubules suspended in UW-gluconate preservation solution. Cryobiology 1996; 33: 196204.
  • 8
    Polyak, MM, Arrington, BO, Stubenbord, WT, Boykin, J, Brown, T, Jean-Jacques, MA, Estevez, J, Kapur, S, Kinkhabwala, M. The influence of pulsatile preservation on renal transplantation in the 1990s. Transplantation 2000; 69: 249258.
  • 9
    Land, W, Schneeberger, H, Schleibner, S, Illner, W, Abendroth, D, Rutili, G, et al. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 1994; 57: 211217.
  • 10
    Nishida, T, Morita, S, Miyamoto, K, Masuda, M, Tominaga, R, Kawachi, Y, Yasui, H. The effect of lazaroid (U74500A), a novel inhibitor of lipid peroxidation, on 24-h heart preservation. A study based on a working model using cross-circulated blood-perfused rabbit hearts. Transplantation. 1996 Jan 27; 61: 1949.
  • 11
    Shackleton, CR, Ettinger, SL, Scudamore, CH, Toleikis, PF, Keown, PA. Effect of a 21-aminosteroid, U74006F, on lipid peroxidation and glomerulotubular function following experimental renal ischemia. J Surg Res. 1994 Oct; 57: 4337.
  • 12
    Todo, S, Hamada, N, Zhu, Y, Zhang, S, Subbotin, V, Nemoto, A, Takeyoshi, I, Starzl, TE. Lazaroid U-74389G for 48-h canine liver preservation. Transplantation. 1996 Jan 27; 61: 18994.
  • 13
    Huang, H, Patel, PB, Salahudeen, AK. Lazaroid compounds prevent early but not late stages of oxidant-induced cell injury: potential explanation for the lack of efficacy of lazaroids in clinical trials. Pharmacol Res. 2001 Jan; 43: 5561.
  • 14
    Burns, A, Davies, D, McLaren, A, Cerundolo, L, Morris, P, Fuggle, S. Apoptosis in ischemia/reperfusion injury of human renal allografts. Transplantation 1998; 66: 872876.
  • 15
    Jassem, W, Fuggle, S, Rela, M, Koo, D, Heaton, N. The role of mitochondria in ischaemia/reperfusion injury. Transplantation 2002; 73: 493499.
  • 16
    Korge, P, Langer, G. Mitochondrial Ca2+ uptake, efflux and sarcolemmal damage in Ca2+ overloaded cultured rat cardiomyocytes. Am J Physiol 1998; 274: H2085.
  • 17
    Steinlechner-Maran, R, Eberl, T, Kunc, M, Schrocksnadel, H, Margreiter, R, Gnaiger, E. Respiratory defect as an early event in preservation-reoxygenation injury of endothelial cells. Transplantation 1997; 63: 136.
  • 18
    Sasaki, S, Yasuda, K, McCully, J, LoCicero, J. Calcium channel blocker enhances lung preservation. J Heart Lung Transplan 1999; 18: 127132.
  • 19
    Ramella-Virieux, S, Steghens, J, Barbieux, A, Zech, P, Pozet, N, Hadj-Aissa, A. Nifedipine improves recovery function of kidneys preserved in a high-sodium, low-potassium cold-storage solution: study with isolated perfused rat kidney technique. Nephrol Dial Transplant 1997; 12: 449455.
  • 20
    Tenschert, W, Harfmann, P, Meyer-Moldenhauer, W, Arndt, R, Klosterhalfen, H. Kidney protective effect of diltiazem after renal transplantation with long cold-ischaemia time and triple-drug immunosuppression. Transplant Proc 1991; 23: 13341335.
  • 21
    Matsumoto, K, Honda, K, Kobayashi, N. Protective effect of heat preconditioning of rat liver graft resulting in improved transplant survival. Transplantation 2001; 71: 862868.
  • 22
    Kuroda, Y, Hiraoka, K, Tanioka, Y, et al. Role of adenosin in preservation by the two-layer method of ischemically damaged canine pancreas. Transplantation 1994; 57: 10171020.
  • 23
    Lakey, J, Tsujimura, T, Shapiro, A, Kuroda, Y. Preservation of the human pancreas before islet isolation using a two-layer (UW solution-perfluorochemical) cold storage method. Transplantation 2002; 74: 18091811.
  • 24
    Matsumoto, S, Rigley, T, Qualley, S, al e. Efficacy of oxygen-charged static twolayer method for short-term pancreas preservation and islet isolation from non-human primate and human pancreata. Cell Transplant: in press.
  • 25
    Kuroda, Y, Kawamura, T, Tanioka, Y, Morita, A, Hiraoka, K, Matsumoto, S, et al. Heart preservation using a cavitary two-layer (University of Wisconsin solution/perfluorochemical) cold storage method. Transplantation 1995; 59: 699701.
  • 26
    Tsujimura, T, Suzuki, Y, Takahashi, T, Yoshida, I, Fujino, Y, Tanioka, Y, et al. Succeesful 24-h preservation of canine small bowel using the cavitary two-layer (University of Wisconsin solution/perfluorochemical) cold storage method. Am J Transplant 2002; 2: 4204.
  • 27
    Chen, W, Bennett, C, Wang, M, Dragun, D, Tian, L, Stecker, K, et al. Perfusion of kidneys with unformulated “naked” intercellular adhesion molecule-1 antisense oligodeoxynucleotides prevents ischemic/reperfusion injury. Transplantation 1999; 68: 8807.
  • 28
    Stepkowski, S. Development of antisense oligodeoxynucleotides for transplantion. Curr Opin Mol Ther 2000; 2: 304317.
  • 29
    Stepkowski, S, Chen, W, Bennett, C, Condon, T, Stecker, K, Tian, L, et al. Phosphorothioate/methoxyethyl-modified ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injury. Transplant Proc 2001; 33: 37053706.
  • 30
    Haug, C, Colvin, R, Delmonico, F, Auchinloss, H, Tolkoff-Rubin, N, Preffer, F, et al. A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 1993; 55: 766772.
  • 31
    Matsuyama, M, Akioka, K, Okamoto, M, Kadotani, Y, Nakamura, K, Ushigome, H, et al. Control fo renal ischemic reperfusion injury by antisense oligodeoxynuclotide of tissue factor. Transplant Proc 2003; 35: 103104.
  • 32
    Ushigome, H, Sano, H, Okamoto, M, Kadotani, Y, Nakamura, K, Akioka, K, et al. The role of tissue factor in renal ischemic reperfusion injruy of the rat. J Surg Res 2002; 102: 1029.
  • 33
    Fuller, B, Pegg, D. The assessment of renal preservation by normothermic bloodless perfusion. Cryobiology 1976; 13: 10331044.
  • 34
    Schon, M, Kollmar, O, Wolf, S, Schrem, H, Matthes, M, Akkoc, N, et al. Liver transplantation after organ preservation with normothermic extracorporeal perfusion. Ann Surg 2001; 233: 114123.
  • 35
    Imber, C, Peter, SS, Cenarruzabeitia, I, Pigott, D, James, T, Taylor, R, et al. Advantages of normothermic perfusion over cold storage in liver preservation. Transplantation 2002; 73: 701709.
  • 36
    Brasile, L, Stubenitsky, B, Booster, M, Lindell, S, Araneda, D, Buck, C, et al. Overcoming severe renal ischemia: the role of ex vivo warm perfusion. Transplantation 2002; 73: 897901.
  • 37
    Butler, A, Rees, M, Wight, D, Casey, N, Alexander, G, White, D, et al. Successful extracoporeal porcine liver perfusion for 72 h. Transplantation 2002; 73: 12121218.
  • 38
    Valero, R, Cabrer, C, Oppenheimer, F, Trias, E, Sanchez-Ibanez, J, Cabo, F, et al. Normothermic recirculation reduces primary graft dysfunction of kidneys obtained from non-heart-beating donors. Transpl Int 2000; 13: 303310.
  • 39
    Gomez, M, Alvarez, J, Arias, J, Barrio, R, Muguerza, J, Balibrea, J, et al. Cardiopulmonary bypass and profound hypothermias as a means for obtaining kidney grafts from irreversible cardiac arrest donors: Cooling techinique. Transplant Proc 1993; 24: 15011502.
  • 40
    Koyama, I, Ogawa, N, Watanabe, T, Taguchi, Y, Asami, H, Nagashima, N, et al. Utilisation of warm ischemic livers from non-heart beating donors by portable cardiopulmonary bypass and heterotopic transplantation. Transplant Proc 1996; 28: 18781879.
  • 41
    Saunders, A, Ogle, M, Ewy, G. Coronary perfusion pressure during cardiopulmonary resuscitation. Am J Emerg Med 1985; 3: 1114.
  • 42
    Shirakura, R, Matsuda, H, Nakata, S, Kaneko, M, Miyagawa, S, Fukushima, N, et al. A new method to harvest multiple organs from non-heart beating donors by use of a percutaneous cardiopulmonary support machine. Transplant Proc 1992; 24: 13291330.
  • 43
    Watanabe, T, Koyama, I, Taguchi, Y, Ogawa, N, Omoto, R. Salvage of warm ischemic pancreas from non-heart-beating donors by a core-cooling method with cardiopulmonary bypass. Transplant Proc 1992; 24: 13311332.
  • 44
    Nishinaka, T, Tatsumi, E, Taenaka, Y, Katagiri, N, Ohnishi, H, Shioya, K, et al. At least thirty-four days of animal continuous perfusion by a newly developed extracorporeal membrance oxygenation system without systemic anticoagulants. Artif Organs 2002; 26: 548551.
  • 45
    Noma, A. ATP-regulated K+ channels in cardiac muscle. Nature 1983; 305: 147148.
  • 46
    Cohen, M, Baines, C, Downey, J. Ischemic preconditioning: from adenosine receptor to KATP channel. Annu Rev Physiol 2000; 62: 79109.
  • 47
    Lee, H, Emala, C. Protein kinase C and G(i/o) proteins are involved in adenosine and ischemic preconditioning-mediated renal protection. J Am Soc Nephrol 2001; 12: 233240.
  • 48
    Yadav, S, Sindram, D, Perry, D, Clavien, P. Ischemic preconditioning protects the mouse liver by inhibition of apoptosis though a caspase-dependent pathway. Hepatology 1999; 30: 12231232.
  • 49
    Clavien, P, Yadav, S, Sindram, D, Bentley, R. Protective effects of ischemic preconditioning for resection performed under inflow occlusion in humans. Ann Surg 2000; 232: 155162.
  • 50
    Redaelli, CA, Tien, YH, Kubulus, D, Mazzucchelli, L, Schilling, MK, Wagner, AC. Hyperthermia preconditioning induces renal heat shock protein expression, improves cold ischemia tolerance, kidney graft function and survival in rats. Nephron 2002 Apr; 90: 48997.
  • 51
    McCormick, PH, Chen, G, Tierney, S, Kelly, CJ, Bouchier-Hayes, DJ. Clinically applicable thermal preconditioning attenuates leukocyte-endothelial interactions. J Am Coll Surg. 2003 Jul; 197: 718.
  • 52
    Ritossa, F. A new puffing pattern induced by temperature shock and DNP in Drosophila. Experentia 1962; 18: 571573.
  • 53
    Hiratsuka, M, Yano, M, Mora, B, Nagahiro, I, Cooper, J, Patterson, G. Heat shock pretreatment protects pulmonary isografts from subsequent ischemiareperfusion injury. J Heart Lung Transplant 1998; 17: 12381246.
  • 54
    Perdrizet, G, Kaneko, H, Buckley, T, Fishman, M, Pleau, M, Bow, L, et al. Heat shock and recovery protects renal allografts from warm ischemic injury and enhances HSP72 production. Transplantat Proc 1993; 25: 16701673.
  • 55
    Kelly, K, Baird, N, Greene, A. Induction of stress response proteins and experimental ischemia/reperfusion. Kid Int 2001; 59: 17981802.
  • 56
    Redaelli, C, Tien, Y, Kubulus, D, Mazzucchelli, L, Schilling, M, Wagner, A. Hyperthermia preconditioning induces renal heat shock protein expression, improves cold ischemia tolerance, kidney graft function and survival in rats. Nephron 2002; 90: 489497.
  • 57
    Meldrum, K, Burnett, A, Meng, X, Misseri, R, Shaw, M, Gearhart, J, et al. Liposomal delivery of heat shock protein 72 into tubular cells blocks nuclear factor-kappaB activation, tumour necrosis factor-alpha production, and subsequent ischemia-induced apoptosis. Circ Res 2003; 92: 2939.
  • 58
    Wang, C, Zuo, X, Carpenter, D, Jordan, S, Nicolaidou, E, Toyoda, M, et al. Prolongation of cardiac allograft survival with intracoronary viral interleukin-10 gene transfer. Transplant Proc 1999; 31: 951952.
  • 59
    Olthoff, K, Judge, T, Gelman, A, Shen, Xd, Hancock, W, Turka, L, et al. Adenovirus-mediated gene transfer into cold-preserved liver allografts: survival pattern and unresponsiveness following transduction with CTLA4Ig. Nat Med 1998; 4: 194200.
  • 60
    Swenson, K, Ke, B, Wang, T, Markowitz, J, Maggard, M, Spear, G, et al. Fas ligand gene transfer to renal allografts in rats: effects on allograft survival. Transplantation 1998; 65: 155160.
  • 61
    Poston, R, Ennen, M, Pollard, J, Hoyt, E, Billingham, M, Robbins, R. Ex vivo gene therapy prevents chronic vascular disease in cardiac allografts. J Thorac Cardiovasc Surg 1998; 100: 2035.
  • 62
    Fry, J, Morris, P, Wood, K. Adenoviral transfer of a single donor-specific MHC Class I gene to recipient bone marrow cells can induce specific immunological tolerance. Gene Ther 2002; 9: 220226.
  • 63
    Brasile, L, Stubenitsky, B, Booster, M, Arenada, D, Haisch, C, Kootstra, G. Transfection and transgene expression in a human kidney during ex vivo warm perfusion. Transplant Proc 2002; 34: 2624